1. Home
  2. PDYN vs SLN Comparison

PDYN vs SLN Comparison

Compare PDYN & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDYN
  • SLN
  • Stock Information
  • Founded
  • PDYN 1983
  • SLN 1994
  • Country
  • PDYN United States
  • SLN United Kingdom
  • Employees
  • PDYN N/A
  • SLN N/A
  • Industry
  • PDYN Wholesale Distributors
  • SLN Biotechnology: Pharmaceutical Preparations
  • Sector
  • PDYN Industrials
  • SLN Health Care
  • Exchange
  • PDYN Nasdaq
  • SLN Nasdaq
  • Market Cap
  • PDYN 297.4M
  • SLN 345.3M
  • IPO Year
  • PDYN N/A
  • SLN N/A
  • Fundamental
  • Price
  • PDYN $6.94
  • SLN $6.65
  • Analyst Decision
  • PDYN Hold
  • SLN Buy
  • Analyst Count
  • PDYN 1
  • SLN 6
  • Target Price
  • PDYN $8.00
  • SLN $39.67
  • AVG Volume (30 Days)
  • PDYN 1.5M
  • SLN 192.4K
  • Earning Date
  • PDYN 11-07-2025
  • SLN 11-06-2025
  • Dividend Yield
  • PDYN N/A
  • SLN N/A
  • EPS Growth
  • PDYN N/A
  • SLN N/A
  • EPS
  • PDYN N/A
  • SLN N/A
  • Revenue
  • PDYN $4,357,000.00
  • SLN $25,830,000.00
  • Revenue This Year
  • PDYN N/A
  • SLN N/A
  • Revenue Next Year
  • PDYN $44.25
  • SLN N/A
  • P/E Ratio
  • PDYN N/A
  • SLN N/A
  • Revenue Growth
  • PDYN N/A
  • SLN 18.63
  • 52 Week Low
  • PDYN $1.69
  • SLN $1.97
  • 52 Week High
  • PDYN $14.95
  • SLN $18.18
  • Technical
  • Relative Strength Index (RSI)
  • PDYN 37.78
  • SLN 53.59
  • Support Level
  • PDYN $7.09
  • SLN $5.81
  • Resistance Level
  • PDYN $8.50
  • SLN $7.39
  • Average True Range (ATR)
  • PDYN 0.55
  • SLN 0.61
  • MACD
  • PDYN -0.18
  • SLN -0.12
  • Stochastic Oscillator
  • PDYN 21.24
  • SLN 43.04

About PDYN Palladyne AI Corp.

Palladyne AI Corp is a software company focused on autonomy for robotic systems and solutions. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in structured and unstructured environments. AI and ML software platform of the company empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: